No single spinal cord stimulator is universally the best. The four major manufacturers (Nevro, Abbott, Boston Scientific, and Medtronic) each offer devices with distinct strengths, and the right choice depends on your pain condition, lifestyle, and how your body responds during a trial period. About 86% of patients achieve at least 50% pain relief during a stimulator trial, and roughly 77% maintain that relief long-term with a permanent implant. But the device that gets you there varies from person to person.
How the Major Devices Compare
The U.S. market has four primary manufacturers, each with a flagship platform that takes a slightly different approach to pain relief.
Nevro Senza Omnia is the most widely implanted system in recent clinical practice, used in nearly 79% of cases in one large institutional review of 505 trials. Its signature feature is 10 kHz high-frequency stimulation, which delivers pain relief without the tingling sensation (paresthesia) that older systems produce. The Senza Omnia can also run burst stimulation simultaneously with high frequency, and it doesn’t require the detailed nerve mapping that some other systems need during programming.
Abbott Proclaim XR stands out for two practical reasons: it comes in a recharge-free version, eliminating the regular charging sessions other devices require, and it can be controlled through an iPhone app via Bluetooth. Abbott also offers the only FDA-cleared remote programming system, called NeuroSphere Virtual Clinic, which lets your doctor adjust your stimulation settings in real time through a secure video connection. If you live far from a pain clinic, this is a meaningful advantage. The Proclaim line also adjusts stimulation intensity automatically when you change posture.
Boston Scientific WaveWriter offers flexibility by running burst and tonic stimulation simultaneously, something most competitors can’t do. It delivers paresthesia-free stimulation at 1.2 kHz and also offers a “micro-burst” programming option. This versatility makes it a strong option for patients who might benefit from blending waveform types.
Medtronic Intellis and Inceptiv features the smallest battery (the thinnest implantable pulse generator on the market), which matters if you’re thin or concerned about the device being visible under the skin. Medtronic’s newer Inceptiv system is notable for full-body MRI compatibility at both 1.5T and 3T field strengths, which is important since many patients with chronic pain conditions need periodic MRI scans. The Intellis offers both “low dose” 40 Hz and “high dose” 1,000 Hz stimulation modes.
Waveform Types Matter More Than Brand
The type of electrical signal your stimulator delivers often matters more than which company made it. There are three main waveform categories, and most modern devices can deliver more than one.
Tonic stimulation is the original approach, delivering a steady low-frequency pulse that produces a tingling sensation in the painful area. It works by essentially replacing pain signals with that tingling. Many patients find this effective, but some dislike the constant paresthesia or find it less effective over time.
High-frequency stimulation (typically at 10 kHz) eliminates the tingling entirely. Brain activity studies show it shifts neural rhythms from slower patterns to faster alpha-wave activity in the sensory regions of the brain, which correlates with pain relief without any sensation from the device itself.
Burst stimulation delivers packets of pulses that mimic natural nerve firing patterns. Neurophysiology research shows burst stimulation has the broadest effect on pain processing, modulating both the sensory and emotional components of pain through distinct brain pathways. In patients with diabetic neuropathy, burst stimulation reduced pain by 44%, and 67% of those patients got better relief from burst than from tonic stimulation alone. The average pain score dropped from 70 (out of 100) before implantation to 28 with tonic stimulation, then further to 16 with burst.
Seven of the nine SCS systems currently available in the U.S. can deliver burst stimulation, so you’re not locked into one brand to access it.
Closed-Loop Technology: A Newer Advantage
Traditional stimulators are “open loop,” meaning they deliver the same electrical output regardless of what your body is doing. If you bend over, cough, or shift in bed, the distance between your spinal cord and the electrode changes, and you may feel a sudden jolt of overstimulation or a drop in pain relief. Adjusting this requires you to manually change settings or wait for your next clinic visit.
Closed-loop systems solve this by measuring the electrical response of your spinal cord nerves with every single pulse. The device reads these signals as a real-time proxy for how well the stimulation is reaching the target nerves, then automatically adjusts the next pulse to keep you in the therapeutic sweet spot. This happens continuously, even during sudden movements like sneezing or deep breathing. The result is more consistent pain relief throughout the day without needing to fiddle with a remote control.
Battery Life and Daily Maintenance
One of the most practical differences between devices is how they’re powered. Rechargeable systems last 10 to 25 years or longer before the battery needs surgical replacement, but they require regular charging sessions ranging from 15 minutes to 2 hours depending on the device and your stimulation settings. Non-rechargeable systems (like Abbott’s Proclaim XR Recharge-Free) eliminate this hassle entirely but have a battery life of roughly 2 to 5 years, meaning you’ll need more replacement surgeries over your lifetime. A rechargeable system typically requires 2.6 to 4.2 fewer battery replacement procedures compared to non-rechargeable options.
Your tolerance for a charging routine matters here. Some people find 30 minutes of charging while watching TV perfectly manageable. Others, especially those with limited hand dexterity or active lifestyles, prefer never thinking about it.
MRI Compatibility Varies Widely
Five of the currently available SCS systems are cleared for full-body MRI scanning, but conditions apply. Two systems only allow head and extremity imaging, one permits only cranial scans, and one is not MRI compatible at all. Medtronic’s Inceptiv system specifically supports both 1.5T and 3T full-body MRI, though leads must be connected directly to the pulse generator and other specific conditions must be met.
If you have a condition that requires regular MRI monitoring, or you’re younger and likely to need MRI scans in the future, full-body compatibility should be high on your priority list.
Complications Are Lower Than They Used to Be
Lead migration, where the thin electrode wires shift out of position after implantation, was historically the most common technical problem, occurring in 13% to 23% of cases with older lead designs. Modern percutaneous leads have brought that rate down to 2% to 9%, which is now comparable to surgical paddle leads (0% to 6%). One review of patients with 10 kHz devices found zero cases of lead migration requiring corrective surgery over a two-and-a-half-year period. Infection and device malfunction remain possible but are less frequent with current hardware.
The Trial Period Is Your Best Decision Tool
Before any permanent implant, you’ll undergo a trial lasting about a week where temporary leads are placed and you test the device in your daily life. Success means at least 50% pain relief, and across a large review of 505 trials, 86% of patients met that threshold. Of those who went on to permanent implants, about 77% maintained that level of improvement at their last follow-up.
Several factors influence how well a trial goes. Women tend to have slightly higher conversion rates to permanent implants than men. Younger patients fare somewhat better than older ones. Tobacco use and higher overall medical complexity are both associated with modestly lower odds of a successful trial. These are statistical trends, not hard rules, but they help explain why outcomes vary.
The trial is also your opportunity to test a specific waveform and device platform in your own body. Pain is deeply individual, and two people with the same diagnosis can respond very differently to the same stimulation type. The “best” stimulator is ultimately the one that gives you meaningful relief during your trial and fits your daily life in terms of charging, MRI needs, device size, and how you want to manage your settings over time.